Search the Newsreel

IRSA (NYSE: IRS) inks $4M Ramblas del Plata barter deal

IRSA Inversiones y Representaciones S.A. (NYSE: IRS) has signed a $4 million barter agreement for a new 2,360 sqm lot within the extended first stage of its Ramblas del Plata real estate project. The lot has an estimated total saleable area of 4,500 sqm. …

IRSA director Fernando Adrian Elsztain sells 5,524 common shares for USD 9,336.56

Fernando Adrian Elsztain, a director at IRSA, sold 5,524 common shares for USD 9,336.56 on April 9, 2026, at a price of USD 1.69 per share. Following this transaction, his direct holding in common shares of IRSA has fallen to zero. The Form 4 …

IRSA Inversiones y Representaciones SA Sponsored ADR Revenue Breakdown – DUS:IRY

This article provides a revenue breakdown for IRSA Inversiones y Representaciones SA Sponsored ADR (DUS:IRY), highlighting that Argentina was the largest contributor to its revenue. Last year, Argentina accounted for €306.65 million, a decrease from €402.03 million the previous year. The data is presented …

BNP Paribas Exane Upgrades Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to "Strong Sell"

BNP Paribas Exane has downgraded Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to a "strong sell" rating. This decision contributes to a cautious analyst sentiment, with the company currently holding an average "Reduce" rating and a consensus price target of $23.95. Despite some …

Fresenius Medical Care Number of Employees 2026 | Employee Count & Headcount Data

Fresenius Medical Care AG (FME) had approximately 110,828 total employees worldwide as of March 2026, marking a 3.6% decline since 2023. The company, headquartered in Germany, is actively hiring with 5,692 job postings in 2026, despite a significant year-over-year decline in new postings. Its …

Solesence, Inc. Common Stock (NASDAQ: SLSN) Share Price, SLSN Stock News, SLSN Share Price & Updates

Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients

BEACON-US research initiative is evaluating the clinical outcomes and patient experiences of high-volume hemodiafiltration in routine U.S. clinical practice across diverse patient populations Fresenius Medical Care expands access to the therapy across the U.S. building on two decades of evidence and treatment from over …

IRSA Inversiones y Representaciones SA (IRS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of IRSA Inversiones y Representaciones SA (IRS), specifically focusing on its P/E ratio. The company's current valuation score is 6.55, ranking it 39th out of 47 in the Real Estate Operations industry. While its current P/E ratio stands …

Perfect Presentation for Commercial Services Co. Revenue Breakdown – TADAWUL:7204

FMS|Fresenius Medical Care AG|Price:24.880|Chg%:+0.130

This article provides a comprehensive stock analysis of Fresenius Medical Care AG (FMS), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation. It notes high institutional ownership and a medium-term upward trend prediction for the stock price, despite technicals not fully supporting …

Fresenius Medical Care AG & Co. KGaA (FMS) Expected to Post Quarterly Earnings on Tuesday

Fresenius Medical Care AG & Co. KGaA (FMS) is expected to release its Q2 2026 earnings before market open on Tuesday, August 4th, with analysts forecasting EPS of $0.615 and revenue of $5.484 billion. The company recently reported $1.05 EPS and $5.34 billion revenue …

Price to earnings forward of IRSA Inversiones y Representaciones SA Sponsored ADR – GETTEX:IRY

This article displays the "Price to earnings forward" financial metric for IRSA Inversiones y Representaciones SA Sponsored ADR (IRY) on Gettex, as provided by TradingView. It indicates that the market is currently closed with no trades. The period value and change are also presented, …

IRS|IRSA Inversiones y Representaciones SA|Price:15.570|Chg%:+0.650

TradingKey provides a comprehensive stock analysis for IRSA Inversiones y Representaciones SA (IRS), highlighting its healthy fundamentals, high growth potential, and relatively fair valuation within the Real Estate Operations industry. The company, based in Argentina, operates across various real estate segments including shopping malls, …

IRSA Inversiones y Representaciones SA

This article provides financial information for IRSA Inversiones y Representaciones SA (IRS), including its market capitalization, P/E ratio, and recent stock performance. It highlights that detailed revenue breakdowns by business segments and across various fiscal quarters have not yet been disclosed by the company. …

SLSN|Solesence Ord Shs|Price:0.940|Chg%:-0.055

This article provides detailed real-time quotes, market trends, and analysis for Solesence Ord Shs (SLSN). It includes key financial figures, performance metrics over various periods, technical indicators, and a shareholder breakdown. The page also presents frequently asked questions about the company's stock.

IRSA Inversiones Y Representaciones (NYSE:IRS) Sees Unusually-High Trading Volume - Here's What Happened

Solesence Ord Shs (SLSN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Solesence Ord Shs (SLSN), detailing its current stock performance, market capitalization, and P/E ratio. It highlights an "Earnings Forecast" section within TradingKey's analysis tools for the company, suggesting an outlook on future EPS, revenue, Net Profit, and …

Fresenius Medical Care stock trades steady as dialysis specialist focuses on margin recovery and deb

Fresenius Medical Care stock is currently undergoing a restructuring-driven turnaround, focusing on improving margins, reducing net debt, and streamlining its core dialysis services. The company's financial reports highlight progress in efficiency measures, cost savings, and deleveraging efforts, which are crucial for attracting investors who …

Solésence will report its second-quarter results before markets open Aug. 11

Solésence (Nasdaq: SLSN) announced it will report its second-quarter 2026 financial results before the market opens on Tuesday, August 11, 2026. The company will also host a conference call and webcast on the same day at 7:30 a.m. CT / 8:30 a.m. ET, featuring …

FMC stock trades steadily as Fresenius Medical Care focuses on margin and cash flow improvements

Fresenius Medical Care (FMC) stock is being closely watched as the company prioritizes improving profitability and cash generation amidst challenges like reimbursement pressure and rising labor costs. The global dialysis specialist's revenue is driven by its dialysis services and products, with investors analyzing treatment …

IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of

This article provides a brief overview of IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (NYSE: IRS), focusing on its revenue breakdown by region. The company's top segment revenue primarily came from Argentina, contributing $361.23 million USD last year. The content also lists various …

IRSA Inversiones y Representaciones SA (IRS) Institutional Confidence

The institutional confidence score for IRSA Inversiones y Representaciones SA (IRS) is 3.00, placing it 27th out of 47 in the Real Estate Operations industry. The institutional shareholding proportion has increased to 19.02% quarter-over-quarter. ETHSX is the largest institutional shareholder, with other significant holders …

Solesence, Inc. Revenue Breakdown – NASDAQ:SLSN

The article provides a revenue breakdown for Solesence, Inc. (NASDAQ: SLSN), highlighting its financial performance. The primary source of revenue is identified as the United States, contributing $56.90 million USD last year and $50.52 million USD the year prior.

FMC stock trades steady as Fresenius Medical Care updates earnings outlook

Fresenius Medical Care (FMC) stock is trading steady following the company's updated earnings outlook, driven by consistent growth in dialysis services and products. The company reported a significant increase in net income and revenue for fiscal year 2025, along with positive guidance for 2026, …

IRSA Inversiones y Representaciones SA (IRS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of IRSA Inversiones y Representaciones SA (IRS), listing its major shareholders and institutional holdings. Key investors include Helikon Investments Ltd, VR Capital Group Ltd, and Nomura Investment Management Business Trust. The report also provides a breakdown of shareholder …

Global Apheresis Market to Reach USD 4.41 Billion by 2031, Driven by Plasma-Based Therapies and Automated Technologies

Company Logo Disposables lead the product segment, while plasmapheresis holds the largest procedure share. North America dominates the market. Key players include Terumo, Fresenius, Haemonetics, BD and B. Braun. Apheresis MarketApheresis Market Dublin, July 24, 2026 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product, …

FMC stock trades steady as Fresenius Medical Care updates guidance and focuses on dialysis margins

Fresenius Medical Care (FMC) stock is trading steadily after the company updated its earnings guidance and focused on enhancing dialysis margins. The article details FMC's revenue growth, shifting profitability mix across regions, and the influence of updated guidance and earnings metrics on its stock …

IRS|IRSA Inversiones y Representaciones SA|Price:15.190|Chg%:-0.400

IRSA Inversiones y Representaciones SA (IRS) is an Argentina-based real estate company with relatively healthy fundamentals and high growth potential, though its valuation is considered fair. Analysts have given it a "Buy" rating with a target price providing significant upside. The company has turned …

Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

This article first appeared on GuruFocus. Release Date: July 23, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Quest Diagnostics Inc (NYSE:DGX) reported a strong revenue growth of over 10% in the second …

Fresenius Medical Care stock trades steady as Q1 2026 turnaround plan supports margins

Fresenius Medical Care's Q1 2026 results show lower revenue but improved operating margins, driven by cost-efficiency measures and portfolio adjustments in its ongoing turnaround plan. Despite a challenging reimbursement and labor environment, the company achieved net income growth, underscoring the effectiveness of its restructuring …

FMC stock trades steady as Fresenius Medical Care focuses on profitability and debt reduction

Fresenius Medical Care (FMC) stock is trading steadily as the company prioritizes profitability and debt reduction. Recent financial data indicate modest revenue growth, improved operating margins by 1-2 percentage points, and a reduction in net debt to EBITDA from 3.5x to around 3.0x. The …

Fresenius Medical Care stock reacts to restructuring progress as earnings stabilize

Fresenius Medical Care's stock is under investor scrutiny on Xetra as the company continues its multi-year restructuring program. The company aims to stabilize earnings and cash flow over 2024 and 2025, driven by cost discipline and consistent dialysis demand. Efforts include stream lining operations, …

IRSA Inversiones Y Representaciones (NYSE:IRS) Stock Passes Above 200 Day Moving Average - Should You Sell?

IRSA Inversiones Y Representaciones (NYSE:IRS) saw its stock price cross above its 200-day moving average on Tuesday, reaching $15.63 against an average of $15.58. The company has a current market capitalization of $1.30 billion and a P/E ratio of 4.43. Analysts currently have an …

FMC stock trades steady as Fresenius Medical Care focuses on margin recovery and dialysis demand

Fresenius Medical Care (FMC) stock is holding steady as the company works to improve profitability amidst challenges in the dialysis sector. The article discusses FMC's dual business model of dialysis services and product manufacturing, highlighting the factors influencing revenue, margins, and investor perception. It …

Jefferies Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Jefferies analyst James Vane has reiterated a Sell rating for Fresenius Medical Care AG & Co. KGaA (0H9X), setting a price target of €31.00. This follows similar Sell ratings from Bank of America Securities, while Citi maintained a Hold rating on July 17. The …

CRES6259535 Bond Profile — Key Metrics

This article provides a detailed profile of the CRES6259535 bond issued by IRSA Inversiones y Representaciones SA. Key metrics include an 8.00% coupon, a maturity date of March 31, 2035, and an outstanding amount of $180 million USD. The issuer, IRSA, is an Argentine …